Insights into the Interplay between the Urinary Microbiome and Bladder Cancer: A Comprehensive Review
Open Access
- 21 August 2024
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (16) , 4927
Abstract
New insights in the urinary microbiome have led to a better understanding being built of the shifts in bacterial representations from health to disease; these hold promise as markers for diagnosis and therapeutic responses. Although several efforts have been made to identify a “core urinary microbiome”, different fingerprints have been identified in men and women that shift with age. The main bacterial groups overall include Firmicutes, Actinobacteria, Fusobacteria, and Bacteroidetes. Although patients with bladder cancer have a microbiome that is similar to that of healthy individuals, differences have been observed at the species level with Fusobacterium nucleatum and Ralstonia, and at the genus level with Cutibacterium. Different bacterial representations may influence extracellular matrix composition, affecting tumor metastatic spreading and tumorigenic metalloproteinase expression. Furthermore, gene expression affecting targets of immune therapy, such as PD-L1, has been associated with changes in bacterial representations and therapeutic response to BCG. This comprehensive review aims to examine the influence of the urinary microbiome in bladder cancer.Keywords
This publication has 47 references indexed in Scilit:
- The urinary and prostatic microbiome in non‐neurogenic male LUTS/BPH: A systematic reviewNeurourology and Urodynamics, 2024
- Microbiome Profiling in Bladder Cancer Patients Using the First-morning Urine SampleEuropean Urology Open Science, 2023
- Role of human papillomavirus and associated viruses in bladder cancer: An updated reviewJournal of Medical Virology, 2023
- Integrated Analysis of the Fecal Metagenome and Metabolome in Bladder Cancer in a Chinese PopulationGenes, 2022
- A Perspective of the Urinary Microbiome in Lower Urinary Tract Infections — A ReviewCurrent Urology Reports, 2022
- Human Gut Mycobiome and Fungal Community Interaction: The Unknown Musketeer in the Chemotherapy Response Status in Bladder CancerEuropean Urology Open Science, 2022
- Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer PatientsEuropean Urology Oncology, 2020
- Microbiota Alters Urinary Bladder Weight and Gene ExpressionMicroorganisms, 2020
- The microbiome of the urinary tract—a role beyond infectionNature Reviews Urology, 2015
- Prevention of Recurrence With Epirubicin and Lactobacillus Casei After Transurethral Resection of Bladder CancerJournal of Urology, 2008